Last 12 months
Inside the activity.
3 purchase rows · 2 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 3 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 26, 2009 Filed Mar 2, 2009 23:26 UTC |
CANGIALOSI LORETTA VSr. Vice President, Controller
|
Tax withholdingCommon Stock | 11,042 | $12.70 | $140,233.40 |
DisclosureSEC source: 0000078003-09-000028 · can1965.xml · nonDerivative · entry 3 CANGIALOSI LORETTA V · CIK 0001174449 · Sr. Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 207,871 Read SEC document |
| February 26, 2009 Filed Mar 2, 2009 23:26 UTC |
CANGIALOSI LORETTA VSr. Vice President, Controller
|
GrantCommon Stock | 32,667 | $0.00 | $0.00 |
DisclosureSEC source: 0000078003-09-000028 · can1965.xml · nonDerivative · entry 2 CANGIALOSI LORETTA V · CIK 0001174449 · Sr. Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 218,913 F2 · shares: The reported transaction constitutes the earn-out of Performance-Contingent Shares and Performance Shares. Read SEC document |
| February 26, 2009 Filed Mar 2, 2009 23:26 UTC |
CANGIALOSI LORETTA VSr. Vice President, Controller
|
GrantCommon Stock | 22,702 | $0.00 | $0.00 |
DisclosureSEC source: 0000078003-09-000028 · can1965.xml · nonDerivative · entry 1 CANGIALOSI LORETTA V · CIK 0001174449 · Sr. Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 186,246 F1 · shares: The reported transaction constitutes the grant of restricted stock units. Read SEC document |
| February 26, 2009 Filed Mar 2, 2009 23:26 UTC |
DAMELIO FRANK ASenior Vice President
|
GrantStock Appreciation Rights · Derivative | 223,881 | $0.00 Strike: $12.70 | $0.00 |
DisclosureSEC source: 0000078003-09-000029 · dam1966.xml · derivative · entry 3 DAMELIO FRANK A · CIK 0001194004 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 223,881 Underlying: Common Stock · 223,881 shares Expires 2014-02-26 F2 · derivative.exercise_date: The stock appreciation rights will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant F2 · derivative.expiration_date: The stock appreciation rights will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant Read SEC document |
| February 26, 2009 Filed Mar 2, 2009 23:26 UTC |
DAMELIO FRANK ASenior Vice President
|
GrantCommon Stock | 119,744 | $0.00 | $0.00 |
DisclosureSEC source: 0000078003-09-000029 · dam1966.xml · nonDerivative · entry 1 DAMELIO FRANK A · CIK 0001194004 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 381,506 F1 · shares: The reported transaction constitutes the grant of restricted stock units. Read SEC document |
| February 26, 2009 Filed Mar 2, 2009 23:25 UTC |
FECZKO JOSEPH MSenior Vice President
|
Tax withholdingCommon Stock | 17,404 | $12.70 | $221,030.80 |
DisclosureSEC source: 0000078003-09-000030 · fec1967.xml · nonDerivative · entry 3 FECZKO JOSEPH M · CIK 0001319874 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 428,855 Read SEC document |
| February 26, 2009 Filed Mar 2, 2009 23:25 UTC |
FECZKO JOSEPH MSenior Vice President
|
GrantCommon Stock | 46,042 | $0.00 | $0.00 |
DisclosureSEC source: 0000078003-09-000030 · fec1967.xml · nonDerivative · entry 2 FECZKO JOSEPH M · CIK 0001319874 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 446,259 F2 · shares: The reported transaction constitutes the earn-out of Performance-Contingent Shares and Performance Shares. Read SEC document |
| February 26, 2009 Filed Mar 2, 2009 23:25 UTC |
FECZKO JOSEPH MSenior Vice President
|
GrantCommon Stock | 14,130 | $0.00 | $0.00 |
DisclosureSEC source: 0000078003-09-000030 · fec1967.xml · nonDerivative · entry 1 FECZKO JOSEPH M · CIK 0001319874 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 400,217 F1 · shares: The reported transaction constitutes the grant of restricted stock units. Read SEC document |
| February 26, 2009 Filed Mar 2, 2009 23:26 UTC |
KINDLER JEFFREY BDirector · Chairman & CEO
|
GrantStock Appreciation Rights · Derivative | 637,438 | $0.00 Strike: $12.70 | $0.00 |
DisclosureSEC source: 0000078003-09-000032 · kin1969.xml · derivative · entry 6 KINDLER JEFFREY B · CIK 0001174454 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 637,438 Underlying: Common Stock · 637,438 shares Expires 2014-02-26 F5 · derivative.exercise_date: The stock appreciation rights will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant F5 · derivative.expiration_date: The stock appreciation rights will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant Read SEC document |
| February 26, 2009 Filed Mar 2, 2009 23:26 UTC |
KINDLER JEFFREY BDirector · Chairman & CEO
|
GrantCommon Stock | 250,527 | $0.00 | $0.00 |
DisclosureSEC source: 0000078003-09-000032 · kin1969.xml · nonDerivative · entry 1 KINDLER JEFFREY B · CIK 0001174454 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 570,505 F1 · shares: The reported transaction constitutes the grant of restricted stock units. Read SEC document |
| February 26, 2009 Filed Mar 2, 2009 23:26 UTC |
GOODMAN COREY SSenior Vice President
|
GrantStock Appreciation Rights · Derivative | 93,284 | $0.00 Strike: $12.70 | $0.00 |
DisclosureSEC source: 0000078003-09-000031 · goo1970.xml · derivative · entry 3 GOODMAN COREY S · CIK 0001278411 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,284 Underlying: Common Stock · 93,284 shares Expires 2014-02-26 F2 · derivative.exercise_date: The stock appreciation rights will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant F2 · derivative.expiration_date: The stock appreciation rights will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant Read SEC document |
| February 26, 2009 Filed Mar 2, 2009 23:26 UTC |
GOODMAN COREY SSenior Vice President
|
GrantCommon Stock | 51,865 | $0.00 | $0.00 |
DisclosureSEC source: 0000078003-09-000031 · goo1970.xml · nonDerivative · entry 1 GOODMAN COREY S · CIK 0001278411 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,232 F1 · shares: The reported transaction constitutes the grant of restricted stock units. Read SEC document |
| February 26, 2009 Filed Mar 2, 2009 23:27 UTC |
MACKAY MARTINSenior Vice President
|
GrantStock Appreciation Rights · Derivative | 83,955 | $0.00 Strike: $12.70 | $0.00 |
DisclosureSEC source: 0000078003-09-000033 · mac1968.xml · derivative · entry 6 MACKAY MARTIN · CIK 0001414815 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,955 Underlying: Common Stock · 83,955 shares Expires 2014-02-26 F5 · derivative.exercise_date: The stock appreciation rights will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant F5 · derivative.expiration_date: The stock appreciation rights will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant Read SEC document |
| February 26, 2009 Filed Mar 2, 2009 23:27 UTC |
MACKAY MARTINSenior Vice President
|
GrantPhantom Stock Units · Derivative | 4,234 | $12.70 | $53,771.80 |
DisclosureSEC source: 0000078003-09-000033 · mac1968.xml · derivative · entry 5 MACKAY MARTIN · CIK 0001414815 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,234 Underlying: Common Stock · 4,234 shares Expires not disclosed F3 · derivative.exercise_price: Each unit represents one phantom share of common stock. F4 · derivative.exercise_date: Units represent incentive compensation that has been deferred. Units will be settled in cash following separation from service. F4 · derivative.expiration_date: Units represent incentive compensation that has been deferred. Units will be settled in cash following separation from service. Read SEC document |
| February 26, 2009 Filed Mar 2, 2009 23:27 UTC |
MACKAY MARTINSenior Vice President
|
Tax withholdingCommon Stock | 5,837 | $12.70 | $74,129.90 |
DisclosureSEC source: 0000078003-09-000033 · mac1968.xml · nonDerivative · entry 3 MACKAY MARTIN · CIK 0001414815 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 297,581 Read SEC document |
| February 26, 2009 Filed Mar 2, 2009 23:27 UTC |
MACKAY MARTINSenior Vice President
|
GrantCommon Stock | 37,114 | $0.00 | $0.00 |
DisclosureSEC source: 0000078003-09-000033 · mac1968.xml · nonDerivative · entry 2 MACKAY MARTIN · CIK 0001414815 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 303,418 F2 · shares: The reported transaction constitutes the earn-out of Performance-Contingent Shares and Performance Shares. Read SEC document |
| February 26, 2009 Filed Mar 2, 2009 23:27 UTC |
MACKAY MARTINSenior Vice President
|
GrantCommon Stock | 99,868 | $0.00 | $0.00 |
DisclosureSEC source: 0000078003-09-000033 · mac1968.xml · nonDerivative · entry 1 MACKAY MARTIN · CIK 0001414815 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 266,304 F1 · shares: The reported transaction constitutes the grant of restricted stock units. Read SEC document |
| February 26, 2009 Filed Mar 2, 2009 23:27 UTC |
MCLEOD MARY SSenior Vice President
|
GrantStock Appreciation Rights · Derivative | 83,955 | $0.00 Strike: $12.70 | $0.00 |
DisclosureSEC source: 0000078003-09-000034 · mcl1971.xml · derivative · entry 2 MCLEOD MARY S · CIK 0001209774 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,955 Underlying: Common Stock · 83,955 shares Expires 2014-02-26 F2 · derivative.exercise_date: The stock appreciation rights will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant F2 · derivative.expiration_date: The stock appreciation rights will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant Read SEC document |
| February 26, 2009 Filed Mar 2, 2009 23:27 UTC |
MCLEOD MARY SSenior Vice President
|
GrantCommon Stock | 50,019 | $0.00 | $0.00 |
DisclosureSEC source: 0000078003-09-000034 · mcl1971.xml · nonDerivative · entry 1 MCLEOD MARY S · CIK 0001209774 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,408 F1 · shares: The reported transaction constitutes the grant of restricted stock units. Read SEC document |
| February 26, 2009 Filed Mar 2, 2009 23:27 UTC |
READ IAN CSenior Vice President
|
GrantStock Appreciation Rights · Derivative | 223,881 | $0.00 Strike: $12.70 | $0.00 |
DisclosureSEC source: 0000078003-09-000035 · rea1972.xml · derivative · entry 5 READ IAN C · CIK 0001372915 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 223,881 Underlying: Common Stock · 223,881 shares Expires 2014-02-26 F3 · derivative.exercise_date: The stock appreciation rights will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant F3 · derivative.expiration_date: The stock appreciation rights will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant Read SEC document |
| February 26, 2009 Filed Mar 2, 2009 23:27 UTC |
READ IAN CSenior Vice President
|
Tax withholdingCommon Stock | 17,732 | $12.70 | $225,196.40 |
DisclosureSEC source: 0000078003-09-000035 · rea1972.xml · nonDerivative · entry 3 READ IAN C · CIK 0001372915 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 445,634 Read SEC document |
| February 26, 2009 Filed Mar 2, 2009 23:27 UTC |
READ IAN CSenior Vice President
|
GrantCommon Stock | 53,387 | $0.00 | $0.00 |
DisclosureSEC source: 0000078003-09-000035 · rea1972.xml · nonDerivative · entry 2 READ IAN C · CIK 0001372915 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 463,366 F2 · shares: The reported transaction constitutes the earn-out of Performance-Contingent Shares and Performance Shares. Read SEC document |
| February 26, 2009 Filed Mar 2, 2009 23:27 UTC |
READ IAN CSenior Vice President
|
GrantCommon Stock | 119,744 | $0.00 | $0.00 |
DisclosureSEC source: 0000078003-09-000035 · rea1972.xml · nonDerivative · entry 1 READ IAN C · CIK 0001372915 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 409,979 F1 · shares: The reported transaction constitutes the grant of restricted stock units. Read SEC document |
| February 26, 2009 Filed Mar 2, 2009 23:26 UTC |
RICCIARDI NATALE SSenior Vice President
|
GrantStock Appreciation Rights · Derivative | 74,627 | $0.00 Strike: $12.70 | $0.00 |
DisclosureSEC source: 0000078003-09-000036 · ric1973.xml · derivative · entry 6 RICCIARDI NATALE S · CIK 0001107158 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,627 Underlying: Common Stock · 74,627 shares Expires 2014-02-26 F4 · derivative.exercise_date: The stock appreciation rights will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant F4 · derivative.expiration_date: The stock appreciation rights will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant Read SEC document |
| February 26, 2009 Filed Mar 2, 2009 23:26 UTC |
RICCIARDI NATALE SSenior Vice President
|
Tax withholdingCommon Stock | 14,380 | $12.70 | $182,626.00 |
DisclosureSEC source: 0000078003-09-000036 · ric1973.xml · nonDerivative · entry 3 RICCIARDI NATALE S · CIK 0001107158 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 387,647 Read SEC document |
| February 26, 2009 Filed Mar 2, 2009 23:26 UTC |
RICCIARDI NATALE SSenior Vice President
|
GrantCommon Stock | 43,142 | $0.00 | $0.00 |
DisclosureSEC source: 0000078003-09-000036 · ric1973.xml · nonDerivative · entry 2 RICCIARDI NATALE S · CIK 0001107158 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 402,027 F2 · shares: The reported transaction constitutes the earn-out of Performance-Contingent Shares and Performance Shares. Read SEC document |
| February 26, 2009 Filed Mar 2, 2009 23:26 UTC |
RICCIARDI NATALE SSenior Vice President
|
GrantCommon Stock | 41,899 | $0.00 | $0.00 |
DisclosureSEC source: 0000078003-09-000036 · ric1973.xml · nonDerivative · entry 1 RICCIARDI NATALE S · CIK 0001107158 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 358,885 F1 · shares: The reported transaction constitutes the grant of restricted stock units. Read SEC document |
| February 26, 2009 Filed Mar 2, 2009 23:26 UTC |
RINGO WILLIAM RSenior Vice President
|
GrantStock Appreciation Rights · Derivative | 96,393 | $0.00 Strike: $12.70 | $0.00 |
DisclosureSEC source: 0000078003-09-000037 · rin1974.xml · derivative · entry 3 RINGO WILLIAM R · CIK 0001238325 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,393 Underlying: Common Stock · 96,393 shares Expires 2014-02-26 F2 · derivative.exercise_date: The stock appreciation rights will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant F2 · derivative.expiration_date: The stock appreciation rights will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant Read SEC document |
| February 26, 2009 Filed Mar 2, 2009 23:26 UTC |
RINGO WILLIAM RSenior Vice President
|
GrantCommon Stock | 44,894 | $0.00 | $0.00 |
DisclosureSEC source: 0000078003-09-000037 · rin1974.xml · nonDerivative · entry 1 RINGO WILLIAM R · CIK 0001238325 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 230,283 F1 · shares: The reported transaction constitutes the grant of restricted stock units. Read SEC document |
| February 26, 2009 Filed Mar 2, 2009 23:26 UTC |
SCHULMAN AMY WSenior Vice President
|
GrantStock Appreciation Rights · Derivative | 111,940 | $0.00 Strike: $12.70 | $0.00 |
DisclosureSEC source: 0000078003-09-000038 · sch1975.xml · derivative · entry 4 SCHULMAN AMY W · CIK 0001438226 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,940 Underlying: Common Stock · 111,940 shares Expires 2014-02-26 F3 · derivative.exercise_date: The stock appreciation rights will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant F3 · derivative.expiration_date: The stock appreciation rights will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant Read SEC document |
| February 26, 2009 Filed Mar 2, 2009 23:26 UTC |
SCHULMAN AMY WSenior Vice President
|
GrantCommon Stock | 33,911 | $0.00 | $0.00 |
DisclosureSEC source: 0000078003-09-000038 · sch1975.xml · nonDerivative · entry 1 SCHULMAN AMY W · CIK 0001438226 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,685 F1 · shares: The reported transaction constitutes the grant of restricted stock units. Read SEC document |
| February 26, 2009 Filed Mar 2, 2009 23:26 UTC |
SUSMAN SALLYSenior Vice President
|
GrantStock Appreciation Rights · Derivative | 90,174 | $0.00 Strike: $12.70 | $0.00 |
DisclosureSEC source: 0000078003-09-000039 · sus1976.xml · derivative · entry 3 SUSMAN SALLY · CIK 0001263544 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,174 Underlying: Common Stock · 90,174 shares Expires 2014-02-26 F2 · derivative.exercise_date: The stock appreciation rights will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant F2 · derivative.expiration_date: The stock appreciation rights will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant Read SEC document |
| February 26, 2009 Filed Mar 2, 2009 23:26 UTC |
SUSMAN SALLYSenior Vice President
|
GrantCommon Stock | 45,686 | $0.00 | $0.00 |
DisclosureSEC source: 0000078003-09-000039 · sus1976.xml · nonDerivative · entry 1 SUSMAN SALLY · CIK 0001263544 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 154,367 F1 · shares: The reported transaction constitutes the grant of restricted stock units. Read SEC document |
| February 26, 2009 Filed Mar 3, 2009 22:00 UTC Amendment |
MACKAY MARTINSenior Vice President
|
GrantStock Appreciation Rights · Derivative | 195,896 | $0.00 Strike: $12.70 | $0.00 |
DisclosureSEC source: 0000078003-09-000041 · mac1978.xml · derivative · entry 1 MACKAY MARTIN · CIK 0001414815 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 195,896 Underlying: Common Stock · 195,896 shares Expires 2014-02-26 F1 · shares: Amendment filed to correct the number of stock appreciation rights granted on February 26, 2009. F2 · derivative.exercise_date: The stock appreciation rights will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant F2 · derivative.expiration_date: The stock appreciation rights will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant Read SEC document |
| February 23, 2009 Filed Feb 25, 2009 12:02 UTC |
CANGIALOSI LORETTA VSr. Vice President, Controller
|
Tax withholdingCommon Stock | 3,242 | $13.27 | $43,021.34 |
DisclosureSEC source: 0000078003-09-000025 · can1962.xml · nonDerivative · entry 1 CANGIALOSI LORETTA V · CIK 0001174449 · Sr. Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 163,544 Read SEC document |
| February 23, 2009 Filed Feb 25, 2009 12:03 UTC |
FECZKO JOSEPH MSenior Vice President
|
Tax withholdingCommon Stock | 5,326 | $13.27 | $70,676.02 |
DisclosureSEC source: 0000078003-09-000026 · fec1963.xml · nonDerivative · entry 1 FECZKO JOSEPH M · CIK 0001319874 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 386,087 Read SEC document |
| February 23, 2009 Filed Feb 25, 2009 12:03 UTC |
RICCIARDI NATALE SSenior Vice President
|
Tax withholdingCommon Stock | 4,682 | $13.27 | $62,130.14 |
DisclosureSEC source: 0000078003-09-000027 · ric1964.xml · nonDerivative · entry 1 RICCIARDI NATALE S · CIK 0001107158 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 316,986 Read SEC document |
| February 01, 2009 Filed Feb 3, 2009 21:12 UTC |
SANGER STEPHEN WDirector
|
GrantPhantom Stock Units · Derivative | 5,500 | $0.00 | $0.00 |
DisclosureSEC source: 0000078003-09-000022 · san1960.xml · derivative · entry 1 SANGER STEPHEN W · CIK 0001204994 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,500 Underlying: Common Stock · 5,500 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · shares: Granted pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Unit Award Plan for Non-Employee Directors. F3 · derivative.exercise_date: These units represent deferred director's compensation that are settled in cash or common stock at the director's election, following the reporting person's retirement from the Board of Directors. F3 · derivative.expiration_date: These units represent deferred director's compensation that are settled in cash or common stock at the director's election, following the reporting person's retirement from the Board of Directors. Read SEC document |
| January 30, 2009 Filed Feb 3, 2009 18:13 UTC |
STEERE WILLIAM C JRDirector
|
Tax withholdingCommon Stock | 44,331 | $14.58 | $646,345.98 |
DisclosureSEC source: 0000078003-09-000021 · ste1959.xml · nonDerivative · entry 1 STEERE WILLIAM C JR · CIK 0001033870 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,509,169 Read SEC document |
| December 31, 2008 Filed Jan 5, 2009 12:58 UTC |
BAGGER RICHARD HSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 55 | $17.71 | $974.05 |
DisclosureSEC source: 0000078003-09-000001 · bag1942.xml · derivative · entry 1 BAGGER RICHARD H · CIK 0001372907 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,520 Underlying: Common Stock · 55 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| December 31, 2008 Filed Jan 5, 2009 12:58 UTC |
CANGIALOSI LORETTA VSr. Vice President, Controller
|
GrantPhantom Stock Units SSP · Derivative | 62 | $17.71 | $1,098.02 |
DisclosureSEC source: 0000078003-09-000002 · can1943.xml · derivative · entry 1 CANGIALOSI LORETTA V · CIK 0001174449 · Sr. Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,132 Underlying: Common Stock · 62 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| December 31, 2008 Filed Jan 5, 2009 12:58 UTC |
FECZKO JOSEPH MSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 76 | $17.71 | $1,345.96 |
DisclosureSEC source: 0000078003-09-000004 · fec1945.xml · derivative · entry 1 FECZKO JOSEPH M · CIK 0001319874 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,736 Underlying: Common Stock · 76 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| December 31, 2008 Filed Jan 5, 2009 12:58 UTC |
DAMELIO FRANK ASenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 112 | $17.71 | $1,983.52 |
DisclosureSEC source: 0000078003-09-000003 · dam1944.xml · derivative · entry 1 DAMELIO FRANK A · CIK 0001194004 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,214 Underlying: Common Stock · 112 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| December 31, 2008 Filed Jan 5, 2009 12:58 UTC |
GOODMAN COREY SSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 78 | $17.71 | $1,381.38 |
DisclosureSEC source: 0000078003-09-000005 · goo1946.xml · derivative · entry 1 GOODMAN COREY S · CIK 0001278411 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,547 Underlying: Common Stock · 78 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| December 31, 2008 Filed Jan 5, 2009 12:58 UTC |
KINDLER JEFFREY BDirector · Chairman & CEO
|
GrantPhantom Stock Units SSP · Derivative | 161 | $17.71 | $2,851.31 |
DisclosureSEC source: 0000078003-09-000006 · kin1947.xml · derivative · entry 1 KINDLER JEFFREY B · CIK 0001174454 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,361 Underlying: Common Stock · 161 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| December 31, 2008 Filed Jan 5, 2009 12:58 UTC |
MACKAY MARTINSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 95 | $17.71 | $1,682.45 |
DisclosureSEC source: 0000078003-09-000007 · mac1948.xml · derivative · entry 1 MACKAY MARTIN · CIK 0001414815 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,870 Underlying: Common Stock · 95 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| December 31, 2008 Filed Jan 5, 2009 12:58 UTC |
READ IAN CSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 252 | $17.71 | $4,462.92 |
DisclosureSEC source: 0000078003-09-000008 · rea1949.xml · derivative · entry 1 READ IAN C · CIK 0001372915 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,619 Underlying: Common Stock · 252 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| December 31, 2008 Filed Jan 5, 2009 12:58 UTC |
RICCIARDI NATALE SSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 72 | $17.71 | $1,275.12 |
DisclosureSEC source: 0000078003-09-000009 · ric1950.xml · derivative · entry 1 RICCIARDI NATALE S · CIK 0001107158 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,380 Underlying: Common Stock · 72 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| December 31, 2008 Filed Jan 5, 2009 12:58 UTC |
RINGO WILLIAM RSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 140 | $17.71 | $2,479.40 |
DisclosureSEC source: 0000078003-09-000010 · rin1951.xml · derivative · entry 1 RINGO WILLIAM R · CIK 0001238325 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,640 Underlying: Common Stock · 140 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| December 31, 2008 Filed Jan 5, 2009 12:58 UTC |
SUSMAN SALLYSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 79 | $17.71 | $1,399.09 |
DisclosureSEC source: 0000078003-09-000011 · sus1952.xml · derivative · entry 1 SUSMAN SALLY · CIK 0001263544 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,177 Underlying: Common Stock · 79 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.